John Weberg

Implemented state PATH programs through effective management and oversight of grants and funding.
Collaborated with State Leadership Team to align efforts among partners in public health.
Fostered relationships with local PATH providers to enhance program visibility and impact.
Collected and disseminated program data, ensuring accurate reporting for stakeholders.
Conducted training events, providing essential guidance for successful program execution.
Assessed homeless areas, linking community members to vital resources and information.
Demonstrated expertise in communication, organization, and data analysis within diverse populations.
Worked independently while maintaining collaborative efforts across multiple organizations.

Consultant and Contract work.

• Developed strategic plans to enhance business operations and potential target markets.
• Created potential marketing materials and executed campaigns to attract new business.
• Provided consultation services to clients, addressing their specific needs effectively.
• Streamlined administrative processes, improving efficiency across operations.
• Led team meetings to foster collaboration and align on project goals.
• Coordinated cross-functional teams to deliver high quality results within tight timelines.

Established Medical Affairs department and helped developed Clinical Affairs team.

• Implemented new SOPs for scientific research, data dissemination, and publications.
• Developed and executed strategic plans to support the vision of the organization.
• Collaborated with executive team members on major decisions regarding company-wide initiatives.
• Maintained relationships with key stakeholders by attending meetings and responding promptly to inquiries or requests for information.
• Cultivated a culture of collaboration among department heads to facilitate cross-functional project execution.
• Ensured compliance with applicable laws and regulations related to operations activities.
• Provided organizational leadership and collaborated with executive partners to establish long-term goals, strategies and company policies.
• Created review committees for Post Market Studies and IIS/IIT proposals with FMV assessment.
• Formulated product publication strategy for evidence-based data generation and dissemination.
• Developed in-house repository and searchable library for all publications related to NWM product lines.
• Onboarded new KOLs, boosting study participation in pivotal RCT study by over 900%.
• Managed eight IIS, Post Market Studies, and over 18 publications, abstracts, manuscripts, and peer reviews.

• Provided strategic leadership and direction of all operational and R&D functions for the corneal division to support our First In Human (FIH) trials for efficacy and stability for Laser Induced Refractive Index Change (LIRIC) for the correction of myopia, hyperopia, with or without astigmatism, as well as presbyopia in patients who underwent cataract surgery with suboptimal visual outcomes.
• Defined short- and long-range strategies for clinical trials, primary investigators leading new product innovation into new and existing markets for all SBUs (corneal, contact lens, and IOL).
• Designed launch plans and KOL strategies for new and existing market opportunities for both patient and physician markets, with their respective rollout plans for our disruptive technologies.
• Spearheaded brand development initiatives for new and existing contact lens products to invigorate market penetration and sales. Project on hold due to supply chain issues (COVID), clinical study delays (due to supply chain, and therefore, FDA approval timelines).
• Built up an extensive patent portfolio with the Engineering team, with more than 80 patents filed with the USPTO and other foreign patent offices.
• Coordinated podium presentations and publications with a stable of KOLs to energize interest in Clerio Technologies in the ophthalmic and investment community. This helped to secure $25 million in the Series E investment round.
• Brought in seasoned production and prototype development engineers to speed up timelines, go-to-market strategies, as well as cost reduction and savings on prototypes and pre-production.
• Managed a team of 12 employees (6 direct and 6 indirect), 7 clinical investigators.
• Initiated three new product projects for class 1 devices that fill a niche that only Clerio Technology could potentially fulfill for the best-in-class device for MIGS, SLT, and Wet AMD, for a combined market size of $1-2 billion.
• Trained executives and senior management on performance management through the adoption of the Success Tree principles and focusing on the vital few.
• Instituted proper scientific methodology for clinical experiments and R&D testing.
• Managed a team responsible for the development of high-speed laser scanning systems.

Responsible for global strategy and strategic evidence generation and data dissemination through independent medical education, CME/CE education, and physician presentations from investigator-initiated studies and post-market studies for all product lines in JJSV.

• Directed four regional teams in generating evidence-based data through IIS and PMOS for independent medical education.
• Oversaw alignment of over ninety studies annually with business goals via Post Market Scientific Review Committee.
• Managed a $10 million budget effectively to support educational initiatives.
• Worked collaboratively with R&D, Clinical, Legal, Regulatory, Marketing, HCC, and Executive Leadership on strategic projects.
• Supervised a team of 12 employees focusing on administration, budgeting, and scheduling efficiency.
• Cultivated impactful partnerships with KOLs and industry leaders to drive business growth.
• Implemented innovative solutions for KOL development while refining business strategies based on market trends.

• Directed global strategy for evidence generation and data dissemination through independent medical education and CME/CE education.
• Led four regional teams in developing evidence-based data via investigator-initiated studies and post-market observational studies.
• Ensured alignment of over 90 IIS and PMOS studies annually with business objectives and SOP requirements.
• Managed annual budget of $10 million, optimizing resource allocation across initiatives.
• Collaborated cross-functionally with R&D, Clinical, Legal, Regulatory, Marketing, and Executive Leadership to refine strategies.
• Supervised 12 employees, overseeing administration, budgeting, cost controls, and scheduling protocols.
• Cultivated strategic partnerships with KOLs and industry experts to enhance business development initiatives.
• Executed strategic messaging and publication planning to disseminate clinical data effectively for best practices.

• Developed strategic plans to align departmental goals with organizational objectives.
• Led cross-functional teams to enhance project execution and operational efficiency.
• Managed stakeholder communications to ensure alignment on project timelines and deliverables.
• Coordinated budget management activities to support financial planning and forecasting efforts.
• Implemented performance metrics to monitor progress and drive continuous improvement initiatives.
• Developed training programs for existing staff members as well as new hires.
• Developed team atmosphere to drive supportive and productive work environment.
• Managed an annual budget of $10 million.
• Work cross-functionally with R&D, Clinical, Legal, Regulatory, Marketing, HCC, and the Executive Leadership Team on a continual basis across numerous initiatives, including key opinion leader (KOL) development, the creation of solutions, and the refinement of business strategies utilizing trends in mature and emerging markets.
• Supervised 12 employees, including overseeing administration, budgeting, cost controls, and scheduling protocols.
• Developed impactful and strategic partnerships with KOLs and industry experts to drive business development

• I was asked to develop the Post Market Studies Group for Abbott Medical Optics, which did not exist.
• Created SOPs, strategic plan, and positioning for Medical Affairs/Post Market Studies globally.
• Hired team members to create a team around the globe.
• Developed messaging strategies and study designs for best practices.
• Identified Key Opinion Leaders (KOLs) for post-market studies, peer-reviewed publications, and driving evidence-based best practices.
• Worked with industry teaching programs to build CME and CE programs utilizing evidence-based data.